Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Parkinson's disease (PD) is characterized by the aggregation of alpha-synuclein (αSyn) into amyloid plaques.
• Early-stage soluble αSyn oligomers are more toxic than larger fibrils, potentially through membrane permeabilization.
• The structural basis for αSyn oligomer toxicity remains unclear.

Purpose of the Study:

• To investigate the impact of structurally distinct αSyn oligomers on neuronal electrophysiology.
• To compare the effects of different αSyn oligomer species on neocortical pyramidal cells.

Main Methods:

• Production of two structurally-defined αSyn oligomers with similar morphology but different secondary structures.
• Whole-cell patch clamp recording in mouse neocortical pyramidal neurons.
• Combined experimental and computational modeling to extract electrophysiological parameters.

Main Results:

• Both αSyn oligomer species significantly reduced neuronal input resistance and membrane time constant.
• Oligomers increased neuronal capacitance and the current required for action potential generation.
• A marked reduction in neuronal excitability was observed, with monomeric αSyn having no effect.

Conclusions:

• Structurally similar αSyn oligomers exert comparable effects on neuronal electrophysiology.
• The observed reduction in neuronal excitability may contribute to network dysfunction and cognitive deficits in PD.
• Differences in secondary structure had subtle effects on oligomer activity.